Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cogent Biosciences
Cogent Biosciences
Cogent Biosciences, Inc. Announces Pricing of Public Offering, Generating Approximately $150 Million for Precision Therapies Development
Yahoo Finance
Wed, 06/7/23 - 09:49 pm
Cogent Biosciences
KIT inhibitor
public offering
Cogent Soars on Positive Mid-Stage Data in Rare Blood Disorder
BioSpace
Sun, 06/12/22 - 08:23 pm
EHA
Cogent Biosciences
clinical trials
bezuclastinib
AdvSM